Manufacturing Technology Sample Clauses
The Manufacturing Technology clause defines the ownership, use, and protection of technology, processes, and know-how used in the production of goods under the agreement. It typically specifies whether the manufacturer or the client retains rights to proprietary manufacturing methods, and may address issues such as licensing, confidentiality, and restrictions on sharing or using the technology outside the scope of the contract. This clause is essential for safeguarding intellectual property, preventing unauthorized use or disclosure, and clarifying each party’s rights regarding the technology involved in manufacturing.
Manufacturing Technology. “Manufacturing Technology” means any and all specifications (raw material (including API) and finished product), protocols, documentation and instructions (including validation, quality control and assurance, storage and other supporting documentation) and master batch records Controlled by Santarus, in each case (a) in the form used in the manufacture (including packaging, labeling, quality control and assurance testing and storage and handling) of Licensed Products under authority of Santarus as of the date of GSK’s written notice described in Section 5.3.2 and (b) reasonably necessary for GSK to manufacture or have manufactured Licensed Products pursuant to this Agreement.
Manufacturing Technology. (i) PDL-Lead Manufacturer. Notwithstanding the foregoing, with respect to Collaboration Products or Royalty Products for which PDL is the Manufacturing Party under Article 8 above, PDL shall have the right to decide which Third Party Technology will be used in such Manufacturing, and any agreement pursuant to which PDL acquired or acquires such technology shall be deemed a Third Party License.
(ii) Biogen Idec-Lead Manufacturer. Notwithstanding the foregoing, with respect to Collaboration Products or Royalty Products for which Biogen Idec is the Manufacturing Party under Article 8 above, Biogen Idec shall have the right to decide which Third Party Technology will be used in such Manufacturing, and any agreement pursuant to which Biogen Idec acquired or acquires such technology shall be deemed a Third Party License.
Manufacturing Technology. Within [***] after the Effective Date, Daiichi Sankyo will provide to Rain or to a contract manufacturer selected by Rain and reasonably approved by Daiichi Sankyo in accordance with Section 2.3, the documents, reports, data, analytical reports, and other information listed in Exhibit H. Such provision of documents, reports, data, analytical reports, and any other information will be done through an electronic data room or other reasonable means, as determined by Daiichi Sankyo after consulting with Rain. Daiichi Sankyo will provide such documents, reports, data, analytical reports, and other information in the language in which it was drafted and Daiichi Sankyo shall not be obligated to translate such documents.
Manufacturing Technology. Upon a Trigger Event or exercise of the Sanofi Option, MannKind will: (i) transfer to Sanofi or its Affiliate any and all Manufacturing Technology necessary to enable Sanofi or its Affiliate or sublicensee to Manufacture Product in accordance with the Product Specifications and (ii) otherwise provide Sanofi or its Affiliate the technology transfer services described in Section 6.6(c) reasonably necessary to enable Sanofi or its Affiliate or sublicensee to Manufacture and supply Product in accordance with Product Specifications. At Sanofi’s request, MannKind shall promptly provide to Sanofi copies of all agreements between MannKind or its Affiliates and Third Party suppliers, vendors, or distributors that relate to the supply of any Raw Materials used in or in connection with the Products in the Territory. Upon a Trigger Event or exercise of the Sanofi Option, MannKind shall promptly and reasonably cooperate to assist Sanofi in obtaining the benefits of any Third Party agreements of MannKind relating to the Products (including assisting Sanofi in identifying and contacting such Third Party suppliers, agreeing to relieve such Third Party suppliers of any exclusivity obligations to MannKind, etc.). For the sake of clarity, the costs incurred by MannKind in performing such activities (i) in the event of a Trigger Event, shall be borne by MannKind and shall not be reflected in the Paid Price, Estimated COGS and/or Cost of Goods, and shall not be considered Allowable Expenses for purposes of Exhibit B to the License Agreement and (ii) in the event of the exercise of the Sanofi Option, shall be reimbursed by Sanofi and shall be considered Allowable Expenses for purposes of Exhibit B to the License Agreement.
Manufacturing Technology. Subject to the other terms of this Agreement, ARIAD hereby grants to MERCK a royalty-free, worldwide license during the Term, with the right to grant sublicenses solely as provided in Section 6.2.3, under Licensed Technology and Licensed Patent Rights for the sole purpose of performing its obligations and exercising its rights under the Supply Agreement.
Manufacturing Technology. Applied Manufacturing Option Course Title Course # Offered Plan to Take Grade Credits Prerequisites English Composition & Literature I ENG 101 F/S/SU 3 ENG 100 or appropriate placement score Process Automation and Robotics MNT 217 F 3 CIS 111, MNT 110 Mathematics Elective --- 3 Social Science Elective --- 3 Elective* --- 3-4 English Composition & Literature II ENG 102 F/S/SU 3 ENG 101 Introduction to Business MGT 101 F/S/SU 3 ENG 091 with a grade of “C” or higher and passing the ENG 096 departmental writing final examination essay or appropriate placement score Humanities Elective --- 3 Mathematics Elective --- 3 Science Elective --- 4 Elective* --- 3-4 BUS 205 Project Management (3 credits) ENG 205 Technical & Workplace Writing (3 credits) MGT 211 Principles of Management (3 credits) MNT 103 Solid Modeling (3 credits) MNT 105 Geometric Tolerancing & Dimensioning (4 credits) MNT 216 Manufacturing Processes II (4 credits) MNT 218 Lean Manufacturing & Six Sigma (3 credits)
Manufacturing Technology. If either Party proposes amending the Global Development Plan to include the use or incorporation of any Sanofi Manufacturing Technology, then, as part of the JDC’s review and discussion of such proposed amendment, the Parties will discuss whether Sanofi shall, in its sole discretion, (i) license such Sanofi Manufacturing Technology to Fulcrum, or (ii) Manufacture and supply Licensed Products incorporating such Sanofi Manufacturing Technology for Fulcrum and prior to the JDC approving any amendment to the Global Development Plan to include such Sanofi Manufacturing Technology, Sanofi will confirm whether such Sanofi Manufacturing Technology will be licensed to Fulcrum pursuant to Section 2.11.2(b) or if Sanofi will supply Fulcrum pursuant to Section 2.11.2(c).
Manufacturing Technology. (i) Except as described in SCHEDULE 4.1(H), Seller owns or has the lawful right and license to use the Manufacturing Technology. Except as set forth on SCHEDULE 4.1(H), the Manufacturing Technology contains all of the know-how necessary for the manufacture and sale of the Product in the Territory as and where conducted by Seller during the twelve (12) month period prior to the Closing.
(ii) Except as described in SCHEDULE 4.1(H) Seller has not received any written notice of, and Seller otherwise has no knowledge of, the misappropriation by any third party of the Manufacturing Technology.
(iii) Seller has the full right, power and authority to grant the Licenses.
Manufacturing Technology. Notwithstanding anything contained herein to the contrary, (i) either Party shall have the right to grant sublicenses under the license granted to it under Sections 6.1.1(c) and 6.1.2(c) solely to Third Party subcontractors engaged by such Party to Manufacture API, Collaboration Compound or Product or to Affiliates; provided however, that; (a) such Party shall remain responsible for the satisfactory accomplishment of such work in accordance with the terms and conditions of this Agreement; and (b) each such subcontractor shall enter into a written agreement containing such provisions as are normal and customary for similar types of agreements, and (ii) subject to the limitation set forth in Section 6.1.2(c) with respect Merck Manufacturing Technology and Merck Patent rights that relate to the Manufacture of Product from API, ARIAD shall have the right to grant sublicenses under the license granted to it under Section 6.1.2
Manufacturing Technology. Each party shall provide to the other, free of charge, for use in the manufacture of Bulk Drug Substance, Drug Product Candidates and Drug Products hereunder, any manufacturing technology developed by it in connection with the Research Program or the Development Program, and any improvements made by it to any such technology. Other manufacturing technology which belongs to one party and which is useful in the manufacture of Bulk Drug Substance, Drug Product Candidates or Drug Products shall be made available to the manufacturing party for that purpose, subject to negotiation of a reasonable royalty or other compensation arrangement. If either party (a "Contracting Party") engages an Affiliate or a Third Party in the course of the Development Program to provide assistance to the Contracting Party in the development of processes useful for the manufacture of Bulk Drug Substance, Drug Product Candidates or Drug Products, the Contracting Party will ensure that any processes belonging to that Affiliate or Third Party and made available to the Contracting Party will also be made available to the other party on the same terms offered to the Contracting Party.